- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cancer Of Prostate in New Zealand
Total 9935 results
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States, Russian Federation
-
SpectraCure ABRecruitingRecurrent Prostate CancerUnited States, Canada, United Kingdom, Sweden
-
Carolina Research Professionals, LLCBayerUnknownProstate Cancer MetastaticUnited States
-
Sumitomo Pharma Switzerland GmbHActive, not recruitingMetastatic Castration-Resistant Prostate Cancer | Metastatic Castration-Sensitive Prostate Cancer | Non-Metastatic Castration-Resistant Prostate CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bayer; Janssen, LP; Prostate Cancer Clinical Trials ConsortiumCompletedStage IV Prostate Adenocarcinoma | Hormone-refractory Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
Eli Lilly and CompanySarah Cannon Development InnovationsCompletedProstate Cancer MetastaticUnited States
-
Genta IncorporatedUnknownProstate CancerUnited States
-
BeiGeneTerminatedMetastatic Castration-Resistant Prostate Cancer (mCRPC) | Homologous Recombination Deficiency (HRD)United States, Australia, Puerto Rico, Spain
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Carcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States, Ireland
-
Oxford BioMedicaMedSource LLCTerminatedHormone Refractory Prostate CancerUnited States
-
Effector TherapeuticsCompletedCastrate-resistant Prostate Cancer (CRPC)United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminated
-
National Cancer Institute (NCI)SuspendedCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
RPCR, Inc.UnknownProstate Cancer Early Risk Treated by Radiosurgery | Prostate Cancer Intermediate Risk Treated by RadiosurgeryUnited States
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate CancerFrance, Spain, Canada, Belgium, United Kingdom, United States
-
Dana-Farber Cancer InstituteJanssen Research & Development, LLCActive, not recruitingCastration-resistant Prostate CancerUnited States
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
AstraZenecaRecruitingMetastatic Prostate CancerUnited States, Australia
-
Philips HealthcareWithdrawnProstate CancerUnited States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
AstraZenecaCompletedMetastatic Castration-resistant Prostates CancerIndia, Peru, Saudi Arabia, Egypt, Colombia, Korea, Republic of, Turkey, United Arab Emirates
-
Boston Scientific CorporationSuspendedCancer | ProstateUnited States
-
Corcept TherapeuticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States, United Kingdom
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.; Stand Up To CancerActive, not recruitingMetastatic Prostate CancerUnited States
-
Celgene CorporationPrologue Research InternationalTerminated
-
National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
BayerActive, not recruitingNon-metastatic Castration-resistant Prostate CancerUnited States
-
BayerCompletedNon-metastatic Castration-resistant Prostate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)SuspendedProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8Canada, United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
BayerActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States, United Kingdom, Finland
-
PROCEPT BioRoboticsRecruitingLocalized Prostate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Howard University; Prostate Cancer Clinical Trials ConsortiumCompleted
-
Veru Inc.CompletedProstate Cancer MetastaticUnited States
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Peter MacCallum Cancer Centre, AustraliaCompletedMetastatic Castration Resistant Prostate CancerAustralia
-
Janssen Research & Development, LLCRecruitingAdvanced Prostate CancerFrance, United States
-
James J. Peters Veterans Affairs Medical CenterNot yet recruitingMetastatic Cancer | Neoplasm, ProstateUnited States
-
National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Xanthus Pharmaceuticals, Inc.Completed
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
Weill Medical College of Cornell UniversityConvergent Therapeutics, Inc.WithdrawnProstate Cancer MetastaticUnited States
-
OncoC4, Inc.Prostate Cancer Clinical Trials ConsortiumRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Columbia UniversityBristol-Myers Squibb; Ferring PharmaceuticalsActive, not recruiting
-
NYU Langone HealthTerminated
-
NYU Langone HealthCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Weill Medical College of Cornell UniversityCompleted